Clinical Trial Update: FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial comparing FOLFIRINOX vs FLOT as neoadjuvant chemotherapy for resectable gastric or esophagogastric junction adenocarcinoma; current status unclea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Neoplasms
• Stomach Neoplasms

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• FLOT
• FLUOROURACIL (Fluorouracil)
• FOLFIRINOX
• IRINOTECAN HYDROCHLORIDE (irinotecan hydrochloride)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Blokhin's Russian Cancer Research Center | Conditions: Stomach Neoplasms, Gastrointestinal Neoplasms | Phase 2, Phase 3 | Status: UNKNOWN